Cancer Precursor Conditions and their Detection, An Issue of Hematology/Oncology Clinics of North America

In this issue of <i>Hematology/Oncology Clinics</i>, guest editor Dr. Elizabeth K. O'Donnell brings her considerable expertise to the topic of <b>Cancer Precursor Syndromes and Their Detection</b>. Top experts focus on cancer precursors for different sites, with articles on the risk-benefit analysis of early interception; plasma cell precursors; early detection and interception of lung cancer, cervical cancer, GI cancers, skin cancer; and head and neck cancer; biomarkers and early detection; and more.<ul><li>Contains <b>12 relevant, practice-oriented topics</b> including clonal hematopoiesis of indeterminate potential (CHIP); prostate cancer: early detection and intervention; ductal carcinoma in situ; cancer prevention; and more.</li><li>Provides in-depth <b>clinical reviews on cancer precursor syndromes and their detection</b>, offering actionable insights for clinical practice.</li><li>Presents the <b>latest information on this timely, focused topic</b> under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.</li></ul>